13F filer · CIK 318989 ↗
FIL Ltd
You are looking at Q4 2017. See the latest, Q2 2026 →
Reported value
$35.93B
+3.0% on the quarter before
Positions
512
46 new · 34 sold out
Top 10
23.8%
of the value
Est. gain
+$1.34B
on stocks held all quarter
Est. return
+4.3%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from FIL Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 39% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Exelon Corporation~$195.3MAdded · 0.5% → 1.0%+4,956,124 shares
- F5~$183.7MNew · 0.0% → 0.5%+1,399,587 shares
- Anthem Inc~$182.4MNew · 0.0% → 0.5%+810,610 shares
- Ctrip Com Intl Ltd~$167.5MAdded · 0.9% → 1.2%+3,797,527 shares
- Andeavor~$123.8MAdded · 0.0% → 0.4%+1,083,065 shares
- Oracle~$95.6MAdded · 2.8% → 2.9%+2,021,379 shares
- Vantiv Inc~$95.5MNew · 0.0% → 0.3%+1,299,085 shares
- Berkshire Hathaway Inc Del~$82.5MAdded · 1.7% → 2.0%+416,135 shares
- Ishares TrPUT~$68.8MNew · 0.0% → 0.2%+1,600,000 underlying
- Denali Therapeutics Inc~$65.5MNew · 0.0% → 0.2%+4,184,982 shares
Largest sells
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Baidu~$313.2MCut · 1.5% → 0.5%−1,337,423 shares
- Cigna Corporation~$285.4MCut · 1.2% → 0.5%−1,405,244 shares
- Nxp Semiconductors N V~$170.0MCut · 0.8% → 0.3%−1,452,087 shares
- Dell Technologies Inc~$161.1MCut · 0.9% → 0.5%−1,981,943 shares
- General Electric Co~$131.9MCut · 1.0% → 0.3%−7,556,946 shares
- Willis Towers Watson Pub Ltd~$117.3MCut · 1.7% → 1.2%−778,475 shares
- Fomento Economico Mexicano S~$113.1MCut · 0.6% → 0.2%−1,204,065 shares
- Time Warner Inc~$109.0MCut · 0.5% → 0.1%−1,192,087 shares
- Abbott Labs~$102.3MCut · 1.8% → 1.6%−1,791,682 shares
- L3 Technologies Inc~$96.0MCut · 1.0% → 0.7%−485,116 shares
Holdings
As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AlibabaSPONSORED ADS · shares +0.9% · price −0.2% | 6.2% | $2.24B | −$3.6M | ||||||||
| OracleCOM · shares +10.0% · price −2.2% | 2.9% | $1.06B | −$21.7M | ||||||||
| Citigroup IncCOM NEW · shares −5.3% · price +2.3% | 2.5% | $903.8M | +$20.3M | ||||||||
| AlphabetCAP STK CL A · shares +2.8% · price +8.2% | 2.5% | $892.8M | +$65.7M | ||||||||
| Berkshire Hathaway Inc DelCL B NEW · shares +13% · price +8.1% | 2.0% | $713.4M | +$47.4M | ||||||||
| Johnson & JohnsonCOM · shares +3.0% · price +7.5% | 1.9% | $675.9M | +$45.6M | ||||||||
| Abbott LabsCOM · shares −15% · price +7.0% | 1.6% | $564.9M | +$36.7M | ||||||||
| Pfizer IncCOM · shares −3.2% · price +1.5% | 1.5% | $544.5M | +$7.8M | ||||||||
| CiscoCOM · shares +0.2% · price +13.9% | 1.4% | $491.0M | +$59.8M | ||||||||
| MicrosoftCOM · shares +4.7% · price +14.8% | 1.3% | $480.6M | +$59.3M | ||||||||
| AppleCOM · shares −7.1% · price +9.8% | 1.3% | $459.0M | +$41.0M | ||||||||
| Willis Towers Watson Pub LtdSHS · shares −21% · price −2.3% | 1.2% | $447.9M | −$10.5M | ||||||||
| Verizon Communications IncCOM · shares +0.5% · price +7.0% | 1.2% | $447.4M | +$28.9M | ||||||||
| Jpmorgan Chase & CoCOM · shares +0.5% · price +12.0% | 1.2% | $446.3M | +$47.4M | ||||||||
| Ctrip Com Intl LtdAMERICAN DEP SHS · shares +61% · price −16.4% | 1.2% | $442.3M | −$53.8M | ||||||||
| Molson Coors Brewing CoCL B · shares −2.9% · price +0.5% | 1.2% | $439.5M | +$2.3M | ||||||||
| Wells Fargo Co NewCOM · shares +15% · price +10.0% | 1.1% | $406.0M | +$32.0M | ||||||||
| AkamaiCOM · shares +4.8% · price +33.5% | 1.1% | $388.4M | +$93.0M | ||||||||
| Exelon CorporationCOM · shares +115% · price +4.6% | 1.0% | $365.6M | +$7.5M | ||||||||
| Us Bancorp DelCOM NEW · shares +5.5% · price −0.0% | 1.0% | $360.1M | −$63,486 | ||||||||
| IBMCOM · shares +18% · price +5.7% | 0.94% | $336.2M | +$15.5M | ||||||||
| Bank New York Mellon CorpCOM · shares +1.1% · price +1.6% | 0.92% | $331.2M | +$5.1M | ||||||||
| Amdocs LtdSHS · shares +1.4% · price +1.8% | 0.86% | $309.9M | +$5.4M | ||||||||
| Procter And Gamble CoCOM · shares −4.3% · price +1.0% | 0.85% | $306.6M | +$3.0M | ||||||||
| Amerisourcebergen CorpCOM · shares +0.3% · price +11.0% | 0.81% | $290.5M | +$28.6M | ||||||||
| Total · 512 positions | 100% | $35.93B | +$1.34B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 462 stocks held throughout, up $1.34B (+4.3%).
- Akamai+$93.0M+33%
- Alphabet+$65.7M+8%
- Cisco+$59.8M+14%
- Microsoft+$59.3M+15%
- Mylan N V+$52.7M+35%
- Celgene Corp−$26.8M−28%
- PPL Corporation−$27.3M−18%
- Edison Intl−$42.2M−18%
- General Electric Co−$47.9M−28%
- Ctrip Com Intl Ltd−$53.8M−16%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $139.27B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $128.75B−4% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $133.60B+5% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $127.26B+9% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $117.10B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $105.25B−2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $107.04B−3% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $110.32B+9% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $101.14B+0% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $100.86B+6% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $95.18B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $84.91B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $89.00B+2% | SEC ↗ |
| Q1 2023 | May 11, 2023 | $87.18B+5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $83.33B+7% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $77.76B−7% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $84.03B−14% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $97.56B+0% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $97.50B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $90.05B−3% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $93.16B+6% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $87.86B+8% | SEC ↗ |
| Q4 2020 | Mar 23, 2021 (amended) | $81.21B+1% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $80.63B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $74.16B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $60.86B−16% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $72.13B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $66.13B−0% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $66.34B+4% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $63.83B+13% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $56.35B−17% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $67.62B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $66.31B+82% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $36.38B+1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $35.93B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $34.88B+1% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $34.67B−2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $35.55B+4% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $34.11B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $33.41B+6% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $31.39B−3% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $32.30B | SEC ↗ |